Table 2.
Different insulin resistance biomarkers in patients with colorectal cancer
| Insulin resistance biomarkers | Metastatic colorectal cancer Mean ± SD (n = 24) | Non-metastatic colorectal cancer Mean ± SD (n = 63) | p Value* | FDR adjusted p-value |
|---|---|---|---|---|
| LHR | 3.305 ± 1.129 | 1.892 ± 0.732 | < 0.000* | 0.0005 |
| TCHR | 4.548 ± 0.893 | 3.272 ± 1.023 | < 0.000* | 0.00025 |
| TyG | 3.548 ± 0.893 | 2.272 ± 1.023 | < 0.000* | 0.000167 |
| TGHR | 3.960 ± 2.265 | 2.680 ± 1.351 | 0.001* | 0.00125 |
| AI | 8.716 ± 0.486 | 8.649 ± 0.429 | 0.399 | 0.399 |
*Mann-Whitney test, p < 0.05 is statistically significant
All IR biomarkers except AI remain significant (FDR < 0.05) after Benjamini-Hochberg adjustment